Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Ko

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 11, 1998
Human N-demethylation of (S)-mephenytoin by cytochrome P450s 2C9 and 2B6J W Ko, Z Desta, D A Flockhart
Clinical Pharmacology and Therapeutics|December 9, 1997
Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19S R Donahue, D A Flockhart, D R Abernethy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1997
Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoformsJ W Ko, N Sukhova, D Thacker, et al.
The British Journal of Dermatology|March 24, 2000
Pityriasis lichenoides-like mycosis fungoides in childrenJ W Ko, J Y Seong, K S Suh, et al.
The American Journal of Dermatopathology|October 27, 1999
Congenital multiple plaque-like glomangiomyomaJ S Yang, J W Ko, K S Suh, et al.
British Journal of Clinical Pharmacology|April 12, 2000
In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6J W Ko, Z Desta, N V Soukhova, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Identification and characterization of human cytochrome P450 isoforms interacting with pimozideZ Desta, T Kerbusch, N Soukhova, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Theophylline pharmacokinetics are not altered by lansoprazole in CYP2C19 poor metabolizersJ W Ko, I J Jang, J G Shin, et al.
Cancer Research and Treatment|December 19, 2015
A Study of the Survival Rate of Childhood Cancer in KoreaM H Yang, S H Eun, C S Park, et al.
Drug Research|February 20, 2014
Bioequivalence study of two imatinib formulations after single-dose administration in healthy Korean male volunteersJ A Jung, N Kim, J-S Yang, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 11, 1998
Human N-demethylation of (S)-mephenytoin by cytochrome P450s 2C9 and 2B6J W Ko, Z Desta, D A Flockhart
Clinical Pharmacology and Therapeutics|December 9, 1997
Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19S R Donahue, D A Flockhart, D R Abernethy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1997
Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoformsJ W Ko, N Sukhova, D Thacker, et al.
The British Journal of Dermatology|March 24, 2000
Pityriasis lichenoides-like mycosis fungoides in childrenJ W Ko, J Y Seong, K S Suh, et al.
The American Journal of Dermatopathology|October 27, 1999
Congenital multiple plaque-like glomangiomyomaJ S Yang, J W Ko, K S Suh, et al.
British Journal of Clinical Pharmacology|April 12, 2000
In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6J W Ko, Z Desta, N V Soukhova, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Identification and characterization of human cytochrome P450 isoforms interacting with pimozideZ Desta, T Kerbusch, N Soukhova, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Theophylline pharmacokinetics are not altered by lansoprazole in CYP2C19 poor metabolizersJ W Ko, I J Jang, J G Shin, et al.
Cancer Research and Treatment|December 19, 2015
A Study of the Survival Rate of Childhood Cancer in KoreaM H Yang, S H Eun, C S Park, et al.
Drug Research|February 20, 2014
Bioequivalence study of two imatinib formulations after single-dose administration in healthy Korean male volunteersJ A Jung, N Kim, J-S Yang, et al.
Pageof 2